Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

NCT02059135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Preeclampsia

Interventions

BIOLOGICAL: Recombinant human antithrombin (ATryn)
OTHER: Normal Saline 0.9%

Sponsor

rEVO Biologics